Gene Amplification Adjacent to F3 Linked to Poor Outcomes in Pancreatic Adenocarcinoma
Amplification of ARHGAP29 and SLC44A3 genes adjacent to F3 is associated with worse overall and disease-free survival in pancreatic adenocarcinoma.
Indication
Clinical and regulatory intelligence for Pancreatic Adenocarcinoma with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.